205 related articles for article (PubMed ID: 9614608)
1. Well-being and symptoms in relation to insulin therapy in type 2 diabetes.
de Sonnaville JJ; Snoek FJ; Colly LP; Devillé W; Wijkel D; Heine RJ
Diabetes Care; 1998 Jun; 21(6):919-24. PubMed ID: 9614608
[TBL] [Abstract][Full Text] [Related]
2. Symptoms and well-being in relation to glycemic control in type II diabetes.
Van der Does FE; De Neeling JN; Snoek FJ; Kostense PJ; Grootenhuis PA; Bouter LM; Heine RJ
Diabetes Care; 1996 Mar; 19(3):204-10. PubMed ID: 8742562
[TBL] [Abstract][Full Text] [Related]
3. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
4. Randomized study of two different target levels of glycemic control within the acceptable range in type 2 diabetes. Effects on well-being at 1 year.
van der Does FE; de Neeling JN; Snoek FJ; Grootenhuis PA; Kostense PJ; Bouter LM; Heine RJ
Diabetes Care; 1998 Dec; 21(12):2085-93. PubMed ID: 9839098
[TBL] [Abstract][Full Text] [Related]
5. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Chow CC; Tsang LW; Sorensen JP; Cockram CS
Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
[TBL] [Abstract][Full Text] [Related]
6. [Associations of emotional state and quality of life with lipid concentration, duration of the disease, and the way of treating the disease in persons with type 2 diabetes mellitus].
Lasaite L; Lasiene J; Kazanavicius G; Gostautas A
Medicina (Kaunas); 2009; 45(2):85-94. PubMed ID: 19289898
[TBL] [Abstract][Full Text] [Related]
7. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
[TBL] [Abstract][Full Text] [Related]
8. Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study.
de Sonnaville JJ; Bouma M; Colly LP; Devillé W; Wijkel D; Heine RJ
Diabetologia; 1997 Nov; 40(11):1334-40. PubMed ID: 9389427
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different insulin regimens in elderly patients with NIDDM.
Wolffenbuttel BH; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
Diabetes Care; 1996 Dec; 19(12):1326-32. PubMed ID: 8941458
[TBL] [Abstract][Full Text] [Related]
10. Diabetes-related distress, insulin dose, and age contribute to insulin-associated weight gain in patients with type 2 diabetes: results of a prospective study.
Jansen HJ; Vervoort GM; de Haan AF; Netten PM; de Grauw WJ; Tack CJ
Diabetes Care; 2014 Oct; 37(10):2710-7. PubMed ID: 25011948
[TBL] [Abstract][Full Text] [Related]
11. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551
[TBL] [Abstract][Full Text] [Related]
12. What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries.
Boels AM; Vos RC; Hermans TGT; Zuithoff NPA; Müller N; Khunti K; Rutten GEHM;
BMJ Open; 2017 Jul; 7(7):e016180. PubMed ID: 28701411
[TBL] [Abstract][Full Text] [Related]
13. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
[TBL] [Abstract][Full Text] [Related]
14. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.
Yki-Järvinen H; Dressler A; Ziemen M;
Diabetes Care; 2000 Aug; 23(8):1130-6. PubMed ID: 10937510
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group.
Diabetes Care; 1999 Jul; 22(7):1125-36. PubMed ID: 10388978
[TBL] [Abstract][Full Text] [Related]
16. Treatment satisfaction after commencement of insulin in Type 2 diabetes.
Wilson M; Moore MP; Lunt H
Diabetes Res Clin Pract; 2004 Dec; 66(3):263-7. PubMed ID: 15536023
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas.
Jennings AM; Lewis KS; Murdoch S; Talbot JF; Bradley C; Ward JD
Diabetes Care; 1991 Aug; 14(8):738-44. PubMed ID: 1954811
[TBL] [Abstract][Full Text] [Related]
18. Effect of insulin therapy on quality of life in Type 2 diabetes mellitus: The Fremantle Diabetes Study.
Davis TM; Clifford RM; Davis WA;
Diabetes Res Clin Pract; 2001 Apr; 52(1):63-71. PubMed ID: 11182217
[TBL] [Abstract][Full Text] [Related]
19. Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life?
de Grauw WJ; van de Lisdonk EH; van Gerwen WH; van den Hoogen HJ; van Weel C
Br J Gen Pract; 2001 Jul; 51(468):527-32. PubMed ID: 11462311
[TBL] [Abstract][Full Text] [Related]
20. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
Davis TM; Cull CA; Holman RR;
Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
